Canton, Mass., United States: Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing
Seattle, United States: Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the generation
Osaka, Japan & Cambridge, Mass., United States: − Elritercept is a late-stage, potentially best-in-class activin inhibitor designed to treat anemia
Stayble Therapeutics AB (“Stayble” or the “Company”) announces positive results from the Company’s clinical phase 1b study in lumbar disc herniation
Hellerup, Denmark, November 7, 2024 – UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on
Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has entered a strategic collaboration with NorthX Biologics, a leading CDMO, to advance manufacturing
The following resolutions were passed at Calliditas Therapeutics AB (publ) (“Calliditas”) extraordinary general meeting held today, on 30 September 2024, in
Orismilast Phase 2b results in atopic dermatitis (AD) presented today as a late-breaking oral presentation at the European Academy of
Chesterbrook, Pa., United States: Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentation Additionally, two posters on data
Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.
Copyright© 2025 Creative Bharat Powered By A Buzz Company